Hip Tendinitis Market Leaders by 2018: Almatica Pharma, Inc (U.S.), AstraZeneca (U.K.), Bayer AG (Germany), Boehringer Ingelheim Pharmaceuticals and more.

Hip tendonitis is a condition in which tendons connects various muscles to the hip bone get damaged due to various factors such as increasing age, changing lifestyle, and sports activities. The global hip tendonitis market is witnessing rapid growth due to increasing number of patients with hip tendonitis, increasing geriatric population, and increasing prevalence of diabetes. Moreover, changing lifestyle, increasing government support, and rising awareness among the people are likely to fuel the market growth. On the other hand, strict regulatory rules, and long approval time for the drugs may slow the market growth.

The global hip tendinitis market is expected to grow at a CAGR of 4.55% during the forecast period.

Sample Report Available @ https://www.marketresearchfuture.com/sample_request/4764 .

Prominent players for Global Hip Tendinitis Market:

Almatica Pharma

 Inc (U.S.)

 AstraZeneca (U.K.)

 Bayer AG (Germany)

 Boehringer Ingelheim Pharmaceuticals

 Inc (Germany)

 Merck & Co.

 Inc (U.S.)

 Pfizer (U.S.)

 Abbott (U.S.)

 GlaxoSmithKline plc (U.K.)

 And more…

Segmentation:

The global hip tendinitis market is segmented on the basis of types, treatment, and end users. On the basis of types, the market is segmented into internal snapping hip, external snapping hip, and intra-articular snapping hip.

On the basis of treatment, the market is segmented into diagnosis and therapy. The diagnosis is further segmented into physical exam, imaging tests, and others. Imaging test is further segmented into ultrasound, magnetic resonance imaging (MRI) scans, and others. The therapy is segmented into pharmacological, non-pharmacological, shock wave or surgery, medical devices, and others. The pharmacological therapy is further segmented into OTC drugs, corticosteroids injections, platelet-rich plasma (PRP), and others. The medical devices are further segmented into mechanical band, support tape, pre-cut strips, continuous rolls, and others. On the basis of end users, the market is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Regional Overview:

The Americas dominate the global hip tendinitis market owing to a large patient population, strong government support for research & development, and high health care spending. According to the report published in Rheumatoid Arthritis Support Network, in 2014, over 1.3 million Americans were suffering from rheumatoid arthritis. Additionally, changing lifestyle and eating habit have fuelled the growth of the market.

Check Discount @ https://www.marketresearchfuture.com/check-discount/4764 .

Europe has the second leading hip tendinitis market across the globe which is followed by Asia Pacific. Asia Pacific is the fastest growing market for hip tendinitis. As per statistics, the U.K and Germany have a huge number of patients suffering from diabetes, which is likely to drive the market growth. Asia Pacific hip tendinitis market is majorly driven by India and China owing to a huge geriatric population, and continuously developing healthcare sector have fuelled the growth of the market.

The Middle East and Africa contribute the least to the growth of global hip tendinitis market. The Middle East dominates the market for The Middle East and Africa. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East market. Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition. However, the growth of the Africa market is high due to the presence of opportunities for the development of the market.

LIST OF TABLES:

Table 1 Hip Tendinitis Industry Synopsis, 2017 – 2023

Table 2 Global Hip Tendinitis Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Hip Tendinitis Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Hip Tendinitis Market By Types, 2017 – 2023, (USD Million)

Table 5 Global Hip Tendinitis Market By Treatment, 2017 – 2023, (USD Million)

Table 6 Global Hip Tendinitis Market By End Users, 2017 – 2023, (USD Million)

Table 7 North America Hip Tendinitis Market By Types, 2017 – 2023, (USD Million)

Table 8 North America Hip Tendinitis Market By Treatment, 2017 – 2023, (USD Million)

Table 9 North America Hip Tendinitis Market By End Users, 2017 – 2023, (USD Million)

Table 10 US Market By Types, 2017 – 2023, (USD Million)

Table 11 US Hip Tendinitis Market By Treatment, 2017 – 2023, (USD Million)

Table 12 US Hip Tendinitis Market By End Users, 2017 – 2023, (USD Million)

Table 13 Canada Market By Types, 2017 – 2023, (USD Million)

Table 14 Canada Hip Tendinitis Market By Treatment, 2017 – 2023, (USD Million)

Table 15 Canada Hip Tendinitis Market By End Users, 2017 – 2023, (USD Million)

And more…

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Hip Tendinitis Market

Figure 3 Segmentation Market Dynamics For Global Hip Tendinitis Market

Figure 4 Global Hip Tendinitis Market Share, By Type 2016

Figure 5 Global Hip Tendinitis Market Share, By Treatment 2016

Figure 6 Global Hip Tendinitis Market Share, By End Users, 2016

Figure 7 Global Hip Tendinitis Market Share, By Region, 2016

Figure 8 North America Hip Tendinitis Market Share, By Country, 2016

Figure 9 Europe Hip Tendinitis Market Share, By Country, 2016

Figure 10 Asia Pacific Hip Tendinitis Market Share, By Country, 2016

And more…

For more Inquiry @ https://www.marketresearchfuture.com/enquiry/4764 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.